(HealthDay News) — There’s no way to guarantee that laparoscopic power morcellation for uterine fibroid removal or hysterectomy won’t increase the risk of spreading undetected cancer to other parts of a woman’s body, U.S. health advisers said Friday.
The advisory panel to the U.S. Food and Drug Administration also said that women who do undergo the procedure should sign a written consent stating that they understand the potential risks, the Associated Press reported.
The panel’s advisory opinion follows an April 17 warning from the FDA that the procedure can inadvertently spread cancerous tissue beyond a woman’s uterus and into other parts of her body.
The FDA hasn’t set a decision date on the use of power morcellator devices, the AP said. The agency isn’t obliged to follow the advice or recommendations of its advisory committees but usually does so.